Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury; A Double-blind, Placebo-Controlled, Randomized Clinical Trial

Double Blind ◽

Double Blind Placebo ◽

Patients At Risk

Efficacy and safety of Afalaza in men with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial

Central European Journal of Urology ◽

10.5173/ceju.2018.1803 ◽

2018 ◽

Vol 71 (4) ◽

Keyword(s):

Clinical Trial ◽

At Risk ◽

Benign Prostatic Hyperplasia ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Double Blind Placebo ◽

Risk Of Progression

Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial

Archives of Gynecology and Obstetrics ◽

10.1007/s00404-012-2624-8 ◽

2012 ◽

Vol 287 (4) ◽

pp. 641-645 ◽

Cited By ~ 46

Author(s):

Mehmet B. Sentürk ◽

Yusuf Cakmak ◽

Gazi Yildiz ◽

Pınar Yildiz

Keyword(s):

Clinical Trial ◽

Cesarean Section ◽

Tranexamic Acid ◽

Double Blind ◽

Mild-to-moderate benign prostatic hyperplasia symptoms: Filling the gap. Efficacy and safety of Afalaza in men with benign prostatic hyperplasia at risk of progression: A multicenter, double-blind, placebo-controlled, randomized clinical trial

European Urology Supplements ◽

10.1016/s1569-9056(19)30186-1 ◽

2019 ◽

Vol 18 (1) ◽

pp. e257

Author(s):

A.Z. Vinarov ◽

D. Pushkar ◽

L. Spivak

Keyword(s):

Clinical Trial ◽

At Risk ◽

Benign Prostatic Hyperplasia ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Risk Of Progression

Effects of tranexamic acid on the amount of bleeding following vaginal delivery and its adverse effects: a double-blind placebo controlled randomized clinical trial

The Journal of Maternal-Fetal & Neonatal Medicine ◽

10.1080/14767058.2021.1888911 ◽

2021 ◽

pp. 1-5

Author(s):

Maryam Kashanian ◽

Farideh Dadkhah ◽

Nasim Tabatabaei ◽

Narges Sheikhansari

Keyword(s):

Clinical Trial ◽

Adverse Effects ◽

Tranexamic Acid ◽

Vaginal Delivery ◽

Double Blind ◽

PD24-03 EFFICACY AND SAFETY OF AFALAZA IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA AT RISK OF PROGRESSION: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

The Journal of Urology ◽

10.1097/01.ju.0000555930.36243.a1 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

ANDREY VINAROV* ◽

Dmitriy Pushkar ◽

Leonid Spivak

Keyword(s):

Clinical Trial ◽

At Risk ◽

Benign Prostatic Hyperplasia ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Double Blind Placebo ◽

Risk Of Progression

Intrauterine Instillation of Tranexamic Acid in Hysteroscopic Myomectomy: A Double-Blind, Placebo-Controlled, Parallel-Group Randomized Clinical Trial

Journal of Minimally Invasive Gynecology ◽

10.1016/j.jmig.2019.09.773 ◽

2020 ◽

Vol 27 (6) ◽

pp. 1264-1272.e2

Author(s):

Radwa Rasheedy ◽

Ahmed Makled ◽

Amgad Abou-Gamrah ◽

Hajer Giuma

Keyword(s):

Clinical Trial ◽

Tranexamic Acid ◽

Double Blind ◽

Hysteroscopic Myomectomy ◽

Double Blind Placebo ◽

Parallel Group

Faculty of 1000 evaluation for Double-blind placebo-controlled randomized clinical trial on the efficacy of Aerosal® in the treatment of sub-obstructive adenotonsillar hypertrophy and related diseases.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718129305.793485934 ◽

2013 ◽

Author(s):

Iain Nixon ◽

Hannah Dixon

Keyword(s):

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Adenotonsillar Hypertrophy

Oral Azitromycin Prophylaxis, 250 Mg Once Daily Three-Times a Week, in Primary Antibody Deficiencies: A Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3235640 ◽

2018 ◽

Author(s):

Cinzia Milito ◽

Federica Pulvirenti ◽

Francesco Cinetto ◽

Vassilios Lougaris ◽

Annarosa Soresina ◽

...

Keyword(s):

Clinical Trial ◽

Primary Antibody ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Primary Antibody Deficiencies

Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Pain and Therapy ◽

10.1007/s40122-021-00275-8 ◽

2021 ◽

Author(s):

Xiaofen Liu ◽

Jun Hu ◽

Xianwen Hu ◽

Rui Li ◽

Yun Li ◽

...

Keyword(s):

Clinical Trial ◽

Visceral Pain ◽

Double Blind ◽

Saffron improves life and sleep quality, glycemic status, lipid profile and liver function in diabetic patients: A double‐blind, placebo‐controlled, randomized clinical trial

International Journal of Clinical Practice ◽

10.1111/ijcp.14334 ◽

2021 ◽

Author(s):

Aynaz Tajaddini ◽

Neda Roshanravan ◽

Majid Mobasseri ◽

Aydin Aeinehchi ◽

Pouria Sefid‐Mooye Azar ◽

...

Keyword(s):

Clinical Trial ◽

Liver Function ◽

Sleep Quality ◽

Lipid Profile ◽

Diabetic Patients ◽

Glycemic Status ◽

Double Blind ◽